Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IoLiTec (Ionic Liquids Technologies) is a specialized chemical company focused on the development and production of ionic liquids and nanomaterials for various industrial and life science applications. In the healthcare and biotech sectors, the company's technology is utilized for drug delivery systems, protein stabilization, and as innovative solvents in pharmaceutical processing. IoLiTec offers a comprehensive portfolio of over 500 ionic liquids and provides custom synthesis services to meet specific research and production requirements. The company operates as a key enabler for green chemistry and advanced material science, supporting the optimization of active pharmaceutical ingredient (API) formulations. Their expertise extends to the development of aqueous solutions and specialized electrolytes that enhance the performance of diagnostic tools and biosensors. Headquartered in Germany with a presence in the United States, IoLiTec serves a global client base ranging from academic research groups to large-scale pharmaceutical manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IoLiTec Ionic Liquids Technologies.